Dianthus Therapeutics | Zahlungsmittel Und Äquivalente



Cash And Equivalent Veränderung Datum
Adcock Ingram Holdings ZAR 79.14M 10.28M 2024-12
Alaunos Therapeutics USD 1.09M 592K 2024-12
Avita Medical AUD 14.05M 3.4M 2024-12
Celltrion KRW 829.07B 829.07B 2025-03
Cspc Pharmaceutical 6.78B 1.6B 2024-12
Dianthus Therapeutics USD 13.24M 9.56M 2025-06
Divis Laboratories Ltd 4.15B 31.87B 2025-03
IQVIA Holdings USD 2.04B 299M 2025-06
Kangmei Pharma CNY 894.14M 120.63M 2025-03
Knight Therapeutics CAD 5.81M 3.59M 2024-09
Laboratorios Farma EUR 46.11M 18.92M 2025-06
Malin Corporation EUR 62.1M 26.4M 2024-12
Medical Developments International AUD 17.62M 7.88M 2024-12
Moderna USD 1.28B 344M 2025-06
Neuren Pharmaceuticals AUD 3.15M 582K 2024-12
Organigram Holdings 35.88M 8.42M 2025-06
Organon & Co USD 599M 52M 2025-06
Pharma Mar EUR 21.59M 38.7M 2025-06
Qiagen NV USD 733.82M 95.06M 2025-06
Revvity USD 991.85M 145.77M 2025-06
Sartorius EUR 819M 20.5M 2025-06
Sino Biopharmaceutical CNY 3.38B 2.09B 2024-12
Tectonic Therapeutic USD 287.38M 146.14M 2025-06
Tilray USD 189.7M 15.49M 2024-11
Viatris USD 566.4M 188.6M 2025-06
Xeris Pharmaceuticals USD 59.28M 12.34M 2025-06
Zz Pientze Pharmaceu 1.39B 93.82M 2025-03


Dianthus Therapeutics Zahlungsmittel Und Äquivalente - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Sep 2025.